Lori Friedman
About Lori Friedman
Lori Friedman is the Chief Scientific Officer with a PhD in molecular and cell biology, known for her extensive work in translational oncology and her contributions to STEM education.
Lori Friedman's Title and Role
Lori Friedman serves as the Chief Scientific Officer. In this role, she oversees scientific research and development within her organization, driving innovation and strategic initiatives in molecular and cell biology.
Lori Friedman’s Education
Lori Friedman earned a PhD in molecular and cell biology from the University of California, Berkeley. Additionally, she completed post-doctoral work at the University of Washington and Cambridge University, enhancing her expertise in her field.
Lori Friedman's Career at Genentech
Lori Friedman worked at Genentech for 15 years, where she most recently held the position of head of translational oncology for Genentech Research and Early Development (gRED). During her tenure, she played a significant role in advancing oncology research and drug development.
Scientific Leadership Roles at Exelixis
Prior to her work at Genentech, Lori Friedman held various scientific leadership roles at Exelixis. Her responsibilities included leading research teams and contributing to the development of new treatments and therapies.
Lori Friedman’s Patents and Publications
Lori Friedman is an inventor on 24 issued patents and an author on 90 peer-reviewed publications. These contributions highlight her extensive research in molecular and cell biology and her impact on scientific advancements.
Board Memberships and Non-Profit Work
Lori Friedman serves on the board of directors of Project Scientist, a non-profit organization dedicated to supporting girls in STEM. She also serves on the board of directors of NextRNA Therapeutics, contributing her scientific expertise to both organizations.